Urinary mevalonate excretion rate in type 2 diabetes: Role of metabolic control

Atherosclerosis

Volumn 156, Issue 2, 2001, Pages 357-361

  Scoppola, Alessandro ^b   Montecchi, Francesca R ^a   Menzinger, Guido ^a   Lala, Alberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Glycated hemoglobin; Mevalonate; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B100; CHOLESTEROL; GLIBENCLAMIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENDER; HEMOGLOBIN DETERMINATION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; URINARY EXCRETION;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FEMALE; HEMOGLOBIN A; HUMANS; MALE; MEVALONIC ACID; MIDDLE AGED; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT;

EID: 0035009848     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00660-2     Document Type: Article

References (34)

1. Diabetes and risk of coronary, cardiovascular and all causes of mortality: Findings for 356 000 men screened by the multiple risk factor intervention trial (MRFIT)
2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
3. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease
4. 7S Study Group: Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
5. Dyslipidemia in non-insulin-dependent diabetes mellitus
6. Hypetriglyceridemia in different degrees of glucose tolerance in a Finnish population based study
7. Role of cholesterol in regulating apolipoprotein B secretion by the liver
8. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM
9. Cholesterol metabolism in diabetes. 1. The effect of diabetic control on sterol balance
10. Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus
11. Sterol excretion and cholesterol absorption in diabetics and nondiabetics with and without hyperlipidemia
12. Effects of diabetes mellitus on cholesterol metabolism in man
13. Mevalonic acid in human plasma: Relationship of concentration and circadian rhythm to cholesterol synthesis rates in man
14. Correspondence between plasma mevalonic acid levels and deuterium uptake in measuring human cholesterol synthesis
15. Simultaneous determination of mevalonate and 7-ahydroxycholesterol in human plasma by gas chromatography-mass spectrometry as indices of cholesterol and bile acid biosynthesis
16. Cholesterol synthesis is increased in mixed hyperlipidemia
17. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: A stable isotope study
18. The effects of insulin on plasma mevalonate concentrations in man
19. The effects of insulin on cholesterol synthesis in type 2 diabetes
20. Improved reagent for enzymatic determination of serum cholesterol
21. Triglyceride determination after hydrolysis
22. Cholesterol determination in high density lipoproteins separated by three different methods
23. Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry
24. Acute hyperinsulinemia decreases cholesterol synthesis less in subjects with non-insulin-dependent diabetes mellitus than in non-diabetic subjects
25. Cholesterol absorption, synthesis and LDL metabolism in NIDDM
26. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects
27. Inhibition of cholesterogenesis decreases hepatic secretion of apo B-100 in normolipidemic subjects
28. Multivalent feed-back regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth
29. The mevalonate pathway: Importance in mesangial cell biology and glomerular disease
30. Mevalonate is essential for growth activation of human fibroblasts: Evidence of a critical role of protein glycosylation in the prereplicative period
31. Relationship between mevalonate pathway and arterial myocyte proliferation: In vitro studies with inhibitors of HMG CoA reductase
32. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
33. Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin
34. Determination of farnesyl pyrophosphate in dog and human plasma by high-performance liquid chromatography with fluorescence detection